(Q39062940)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28035914%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

title

Antibody mimicry, receptors and clinical applications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28035914%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28035914%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Angelo C Faini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28035914%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Fabio Morandi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28035914%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

author name string

Alberto L Horenstein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28035914%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Antonella Chillemi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28035914%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Valeria Quarona

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28035914%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Andrea Zito

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28035914%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Valentina Mariani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28035914%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Clara Maria Ausiello

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28035914%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Fabio Malavasi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28035914%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

publication date

1 January 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28035914%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28035914%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28035914%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

issue

3-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28035914%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

page(s)

75-85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28035914%20AND%20SRC:MED&resulttype=core&format=json

Coming-of-Age of Antibodies in Cancer Therapeutics

4 April 2020

cites work

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Allosteric mechanisms of signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

CD38 and bone marrow microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

A series of Fas receptor agonist antibodies that demonstrate an inverse correlation between affinity and potency

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Allostery and cooperativity revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Human CD38 and CD16 are functionally dependent and physically associated in natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

SAR650984, a novel humanized CD38-targeting antibody, demonstrates potent antitumor activity in models of multiple myeloma and other CD38+ hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

CD38 ligation in peripheral blood mononuclear cells of myeloma patients induces release of protumorigenic IL-6 and impaired secretion of IFNγ cytokines and proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

CD38 is expressed on human mature monocyte-derived dendritic cells and is functionally involved in CD83 expression and IL-12 induction

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

The human CD38 gene: polymorphism, CpG island, and linkage to the CD157 (BST-1) gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Allosteric modulation of the adenosine family of receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Tetrameric interaction of the ectoenzyme CD38 on the cell surface enables its catalytic and raft-association activities

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

NAD⁺-Metabolizing Ectoenzymes in Remodeling Tumor-Host Interactions: The Human Myeloma Model

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Adenosine Generated in the Bone Marrow Niche Through a CD38-Mediated Pathway Correlates with Progression of Human Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

The immunotherapy era of myeloma: monoclonal antibodies, vaccines, and adoptive T-cell therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomide

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Seminal CD38 Enhances Human Sperm Capacitation through Its Interaction with CD31.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Continuous cultures of fused cells secreting antibody of predefined specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

CD38 ligation plays a direct role in the induction of IL-1beta, IL-6, and IL-10 secretion in resting human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Wide distribution of an enzyme that catalyzes the hydrolysis of cyclic ADP-ribose

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Combinatorial antibody libraries: new advances, new immunological insights

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Evolution and dynamics of protein interactions and networks.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Immuno-targeting the multifunctional CD38 using nanobody

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Crystal structure of human CD38 extracellular domain

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

CD38 and chronic lymphocytic leukemia: a decade later

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Characterization of a CD38-like 78-kilodalton soluble protein released from B cell lines derived from patients with X-linked agammaglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Contributions of chaperone and glycosyltransferase activities of O-fucosyltransferase 1 to Notch signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Intracellular Aspects of the Process of Protein Synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

The blockade of immune checkpoints in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Complex role of nicotinamide adenine dinucleotide in the regulation of programmed cell death pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Unraveling the contribution of ectoenzymes to myeloma life and survival in the bone marrow niche.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

CD38 and CD157: a long journey from activation markers to multifunctional molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

ADP-ribose/TRPM2-mediated Ca2+ signaling is essential for cytolytic degranulation and antitumor activity of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Separation of functional subsets of human T cells by a monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Protein-protein interactions in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Regulation of notch signaling activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Comparison of tertiary structures of proteins in protein-protein complexes with unbound forms suggests prevalence of allostery in signalling proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Serum total IgG and IgG4 levels in thyroid eye disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Monoclonal antibodies targeting CD38 in hematological malignancies and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Interactome networks and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

A Murine, Bispecific Monoclonal Antibody Simultaneously Recognizing β-Glucan and MP65 Determinants in Candida Species

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

The CD3-gamma delta epsilon transducing module mediates CD38-induced protein-tyrosine kinase and mitogen-activated protein kinase activation in Jurkat T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

Evidence for the T3-associated 90K heterodimer as the T-cell antigen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FHAB-160305

21 January 2018

Identifiers

DOI

10.3233/HAB-160305

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28035914%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

1 reference